Evidence map›Paper›PMID 29499132›Full record

ArticleMolecular cell2018

Mitochondrial Retrograde Signaling in Mammals Is Mediated by the Transcriptional Cofactor GPS2 via Direct Mitochondria-to-Nucleus Translocation.

Maria Dafne Cardamone, Bogdan Tanasa, Carly T Cederquist, Jiawen Huang, Kiana Mahdaviani, Wenbo Li, Michael G Rosenfeld, Marc Liesa, Valentina Perissi

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 1 synthesis or guideline pooled it, 124 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Cocaine remodels mFrontiers in cellular neuroscience · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Mitochondria - the CEO of the cell.Journal of cell science · 2025
    Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Maria Dafne CardamoneBiochemistry Department, Boston University School of Medicine, Boston, MA 02118, USA.
Bogdan TanasaHoward Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Carly T CederquistBiochemistry Department, Boston University School of Medicine, Boston, MA 02118, USA.
Jiawen HuangBiochemistry Department, Boston University School of Medicine, Boston, MA 02118, USA.
Kiana MahdavianiDepartment of Medicine, Boston University School of Medicine, Boston, MA 02118, USA.
Wenbo LiHoward Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Michael G RosenfeldHoward Hughes Medical Institute, Department of Medicine, School of Medicine, University of California, San Diego, La Jolla, CA 92093, USA.
Marc LiesaDepartment of Medicine, Division of Endocrinology and Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA 90095, USA.
Valentina PerissiBiochemistry Department, Boston University School of Medicine, Boston, MA 02118, USA. Electronic address: vperissi@bu.edu.
Boston University · USHoward Hughes Medical Institute · USUniversity of California, Los Angeles · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Transgenic & Knock-out MouseP30DK063491 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PETER J TONTONOZ · 2003 to 2026
$40.4M
Transgenic CoreP30DK046200 · NIDDK · TUFTS MEDICAL CENTER · PI GREENBERG, ANDREW S, PERISSI, VALENTINA · 1992 to 2021
$25.0M
Transcriptional Genomics CoreP01DK074868 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, M · 2007 to 2016
$16.6M
HORMONAL AND DEVELOPMENTAL REGULATION OF GENE EXPRESSIONR01DK018477 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 1986 to 2025
$12.7M
REGULATION OF NEUROENDOCRINE SWITCHING EVENTSR37DK039949 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 1987 to 2020
$12.3M
REGULATION OF NEUROENDOCRINE SWITCHING EVENTSR01DK039949 · NIDDK · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ROSENFELD, MICHAEL G · 1996 to 2024
$2.4M
Ubiquitin-dependent regulation of inflammation and insulin resistanceR01DK100422 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI PERISSI, VALENTINA · 2014 to 2018
$1.8M
Defining the role of GPS2 at the intersection of lipid metabolism and inflammation in adipose tissueF31DK108571 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI CEDERQUIST, CARLY THERESA · 2016 to 2017
$52k
Howard Hughes Medical InstituteNIDDK NIH HHS F31 DK108571NIDDK NIH HHS P01 DK074868NIDDK NIH HHS P30 DK036836NIDDK NIH HHS P30 DK046200NIDDK NIH HHS P30 DK063491NIDDK NIH HHS R01 DK018477NIDDK NIH HHS R01 DK039949NIDDK NIH HHS R01 DK100422NIDDK NIH HHS R37 DK039949
6 · The paper itself

Abstract

As most of the mitochondrial proteome is encoded in the nucleus, mitochondrial functions critically depend on nuclear gene expression and bidirectional mito-nuclear communication. However, mitochondria-to-nucleus communication pathways in mammals are incompletely understood. Here, we identify G-Protein Pathway Suppressor 2 (GPS2) as a mediator of mitochondrial retrograde signaling and a transcriptional activator of nuclear-encoded mitochondrial genes. GPS2-regulated translocation from mitochondria to nucleus is essential for the transcriptional activation of a nuclear stress response to mitochondrial depolarization and for supporting basal mitochondrial biogenesis in differentiating adipocytes and brown adipose tissue (BAT) from mice. In the nucleus, GPS2 recruitment to target gene promoters regulates histone H3K9 demethylation and RNA POL2 activation through inhibition of Ubc13-mediated ubiquitination. These findings, together, reveal an additional layer of regulation of mitochondrial gene transcription, uncover a direct mitochondria-nuclear communication pathway, and indicate that GPS2 retrograde signaling is a key component of the mitochondrial stress response in mammals.

Indexed as

Organelle Biogenesis3T3-L1 CellsActive Transport, Cell NucleusAnimalsCell NucleusHeLa CellsHistonesHumansIntracellular Signaling Peptides and ProteinsMethylationMiceMitochondriaPromoter Regions, GeneticSignal TransductionTranscriptional ActivationGPS2 protein, humanGPS2 protein, mouseHistonesIntracellular Signaling Peptides and ProteinsadipocyteBATGPS2mitochondriamitochondrial retrograde signalingsumotranscriptionubiquitin

Identifiers

PMID29499132
PMCPMC6022402
OpenAlexW2789303432

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.